Print

NovaBay Pharmaceuticals, Inc. to Present at Rodman & Renshaw 14th Annual Healthcare Conference  
9/4/2012 9:28:20 AM

EMERYVILLE, Calif., Sept. 4, 2012 (GLOBE NEWSWIRE) -- NovaBay® Pharmaceuticals, Inc. (NYSE Amex:NBY), a clinical-stage biotechnology company developing its first-in-class, anti-infective Aganocide® compounds for the local non-systemic treatment and prevention of infections, today announced that Tom Paulson, Chief Financial Officer, will present at the Rodman & Renshaw 14th Annual Healthcare Conference held September 9-11, 2012, in New York, NY.
//-->